TransMedics (TMDX) Operating Margin (2018 - 2025)
Historic Operating Margin for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 16.2%.
- TransMedics' Operating Margin rose 125900.0% to 16.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.94%, marking a year-over-year increase of 91000.0%. This contributed to the annual value of 8.49% for FY2024, which is 203800.0% up from last year.
- Per TransMedics' latest filing, its Operating Margin stood at 16.2% for Q3 2025, which was up 125900.0% from 23.24% recorded in Q2 2025.
- TransMedics' Operating Margin's 5-year high stood at 23.24% during Q2 2025, with a 5-year trough of 216.61% in Q3 2021.
- Over the past 5 years, TransMedics' median Operating Margin value was 5.03% (recorded in 2023), while the average stood at 34.27%.
- As far as peak fluctuations go, TransMedics' Operating Margin plummeted by -1587900bps in 2021, and later surged by 1950200bps in 2022.
- TransMedics' Operating Margin (Quarter) stood at 132.57% in 2021, then skyrocketed by 84bps to 21.61% in 2022, then soared by 115bps to 3.21% in 2023, then skyrocketed by 122bps to 7.11% in 2024, then surged by 128bps to 16.2% in 2025.
- Its Operating Margin stands at 16.2% for Q3 2025, versus 23.24% for Q2 2025 and 19.12% for Q1 2025.